 Elegant Marbles and Grani Industries Ltd Q2 FY2026 PAT up QoQ at Rs. 1.21 crore
Elegant Marbles and Grani Industries Ltd Q2 FY2026 PAT up QoQ at Rs. 1.21 crore Mahindra Lifespace Developers Ltd Q2 FY2026 consolidated PAT at Rs. 47.90 crores
Mahindra Lifespace Developers Ltd Q2 FY2026 consolidated PAT at Rs. 47.90 crores Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26
Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26 Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore
Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore
National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore 
              Venus Remedies Limited have received Good Manufacturing Practice (GMP) certification from the Ministry of Health of Moldova for its antibiotic Carbapenem facility. With this certification, we are now well-positioned to further extend our presence in the Eastern European market ensuring access to high quality, effective and reliable antibiotics for healthcare providers and patients across the region.
Shares of Venus Remedies Limited was last trading in BSE at Rs. 310.45 as compared to the previous close of Rs. 305.75. The total number of shares traded during the day was 990 in over 75 trades.
The stock hit an intraday high of Rs. 314.50 and intraday low of 306.35. The net turnover during the day was Rs. 307148.00.